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INTRODUCTION
Craniosynostosis is a disorder characterized by the
premature fusion of the calvarial sutures, causing an
abnormal skull shape. Because this disorder occurs with a
relatively high frequency, estimated at 1 in 2500 individuals,
craniosynostosis represents a relevant medical problem (1).
More than 100 syndromes have been shown to be associated
with this disorder. It is believed that at least 20% of cases are
due to single gene mutations or chromosome abnormalities
(2). Although most cases can be considered both clinically
and genetically heterogeneous, there is evidence that six
genes are involved in many cases: MSX2, FGFR1, FGFR2,
FGFR3, FBN1, and TWISTY (1).
The Msh homeobox 2 (Msx2) gene encodes a home-
odomain transcription factor protein and is expressed in
migrating cranial neural crest cells during development (3).
Msx2 has central roles in craniofacial development (4) and
limb and tissue formation (6). Furthermore, Msx2 over-
expression was demonstrated to be associated with cranio-
synostosis in mice (5,7), indicating that normal craniofacial
formation is dependent on the Msx2 dosage. Corroborating
these findings, increases in the copy number in the MSX2
region have been reported in craniosynostosis patients (8-11).
In the present study, we describe the findings from a
whole-genome array comparative genomic hybridization
(aCGH) analysis of a four-year-old patient exhibiting cranio-
synostosis, microcephaly, psychomotor development delay,
short stature, and cognitive impairment, among other ab-
normalities. We found a gain in a region of chromosome
5q35.2 that contains MSX2 and has been shown to be
associated with craniosynostosis. Quantitative PCR con-
firmed the increase in the MSX2 copy number.
CASE DESCRIPTION
This study was approved by the Hospital das Clı´nicas
Institutional Ethics Committee, andwritten informed consent
was obtained from the family. The propositus (a girl) was the
first live born child of a healthy and non-consanguineous
couple (the mother was 38 years old and the father was 40
years old at the time of conception). Themother is of Japanese
descent, and the father is of African descent. The mother had
experienced two previous miscarriages due to incontinence
of the endocervical isthmus. The pregnancy was uneventful
except for mild vaginal bleeding during the first trimester.
The patient was born preterm (31 weeks) after vaginal
delivery, with Apgar scores of 8 and 9, a weight of 1550 g, a
length of 38.5 cm, and an OFC of 28.0 cm. At birth, the patient
exhibited respiratory distress and underwent orotracheal
intubation (3 days). The patient was hypotonic, had poor
suction, and exhibited neonatal jaundice and metabolic
disturbances (hyponatremia and hypocalcemia). She was
discharged at 2 months of age at a weight of 1910 g. The
patient also exhibited failure to thrive, recurrent otitis and
global developmental delay. She was able to sit without
support at 15 months and able to walk with no support and
say simple words at 24 months.
Physical examination at 19 months showed a weight of
6500 g, a length of 68.5 cm, and an OFC of 42.5 cm. The
patient’s face was peculiar, with a narrowing of the frontal
diameter, upslanting palpebral fissures, an enlarged nasal
root, low and posteriorly rotated ears, bilateral convergent
strabismus, a high arched palate and mild retrognathia.
Neuroimaging studies (CT) revealed coronary craniosynos-
tosis. No heart defects were observed. Abdominal ultra-
sonography showed a mild abnormality of the renal
parenchyma, but the patient’s kidney function is normal.
Phytohemagglutinin (PHA)-stimulated lymphocytes were
subjected to G-banding karyotyping (500 bands) of the
propositus and progenitors. The results were described
according to the recommendations of the ISCN (2008). G-
banding karyotype analysis of the patient showed a normal
46,XX pattern with no structural or numeric variations. The
same was observed for both progenitors.
For the aCGH experiments, DNA from the patient and
progenitors was extracted from blood samples using a
QIAamp DNA Blood Midi kit (Qiagen, Germany). Labeling
and hybridization reactions were performed as recommended
by the manufacturer (Perkin Elmer, Norwalk). aCGH was
performed with Constitutional Chip 4.0 (Perkin Elmer,
Norwalk), which includes 5000 BAC clones spotted in
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Table 1 - Clones that exhibited copy number variation detected through aCGH screening of the patient’s genome.
Clones Status of alteration Cytogenetic location Genomic coordinates (GRCh36/ hg18) Genes present in the region
RP11-203P12 Loss 4q22.1 4:88,282,368- 88,336,595 KLHL8
RP11-603O17 Gain 5q35.2 5:173,984,926- 174,145,340 MSX2
RP11-606P24 Gain 5q35.2 5:174,718,444- 174,907,513 DRD1, SFXN1
RP11-10J21 Loss 8q24.3 8:142,215,092- 142,412,727 DENND3, SLC45A4
RP11-153P4 Loss 9q34.2 9:135,531,566- 135,710,693 SARDH, VAV2
RP11-311J21 Loss 9q34.3 9:136,982,786- 137,166,802 OLFM1
Figure 1 - A spectral image of chromosome 5 from the patient revealing a gain in 5q35.2, which was detected by aCGH.
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duplicate with a resolution of at least 650 kb and human DNA
segments of 100,300 kb distributed through the whole
genome.
The slides were scanned with InnoScan 710 (Innopsys,
Carbonne, France), and MAPIX 4.5 software was used to
generate GPR files. Data analysis was conducted with
SpectralWareH v2.3.3 aCGH Analysis System software (12)
from Perkin Elmer. The computational parameters used
were pin linear normalization, a threshold between 0.7 and
1.3, a Loess alpha of 0.1 for normalization and a confidence
level of 95%. Median values were used for the interpretation
of the results. The Database of Genomics Variants was
consulted to determine the size of chromosome regions and
to identify CNVs (13). These analyses revealed gains in two
neighboring BAC clones on 5q32.2 and losses in 4q22.1,
8q24.3 and 9q34.2-34.3 (Table 1). A spectral image of
chromosome 5 from the patient demonstrating the gain in
5q35.2 is presented in Figure 1. The patients revised
karyotype was 46,XX.arr 4q22.1(88,282,368-88,336,595)x1,
5q35.2(173,984,926-174,145,340)(174,718,444-174,907,513)x5,
8q24.3(142,215,092-142,412,727)x1, 9q34.2q34.3(136,982,786-
137,166,802)x1[hg18].
DNA samples from the patient and progenitors were used
for MSX2 gene copy number assessment. A TaqMan copy
number assay (Applied Biosystems, Foster City, CA) consist-
ing of an MGB probe labeled with FAM and unlabeled PCR
primers for MSX2 (assay Hs01821094_cn) was employed.
Unlabeled primers and a VIC dye-labeled TAMRA probe for
RNase P gene, which is known to be present in two copies
in human diploid genome, were used for normalization.
Reactions were performed as recommended by the manufac-
turer in triplicate. Duplex real-time polymerase chain reactions
were conducted in a 7500 Real-Time PCR System, and the data
were analyzed with CopyCallerTM Software v1.0, both from
Applied Biosystems. Cycle thresholds (CT) were calculated
using the relative quantification method (Applied Biosy-
stems). Copy numbers were calculated by determining the
difference in the CT between the target and control probes
(DCT). Cycle thresholds greater than 32 were excluded from
analyses. A quantitative PCR assay to detect MSX2 CNVs
revealed two copies for both progenitors and five copies for
the patient (Figure 2). Phenotypically normal subjects unre-
lated to the studied family also had two copies. Themean delta
Ct, calculated as the FAM Ct divided by the VIC Ct, and the
standard deviation of the delta Ct were 0.2192¡0.13 for
Subject 1, 0.5772¡0.29 for Subject 2, 0.5807¡0.1 for the
patient’s mother, -0.8858¡0.12 for the patient, 0.3630¡0.16
for Subject 3 and 0.7518¡0.12 for the patient’s father.
DISCUSSION
A search for similar abnormalities in DECIPHER (Database
of Chromosomal Imbalance and Phenotype in Humans
Using Ensembl Resources) (14) returned three cases with
chromosome 4 alterations related to that observed in the
present study (cases 753, 994, and 249573). The phenotypes in
these cases included mental retardation/developmental
delay, short stature, atrial septum defects, hypotonia and
eyelid defects, among other abnormalities. However, it is
important to stress that no correlation between a loss in the
Figure 2 - Assessment of MSX2 copy number variation. The estimated copy number variations for the patient, the progenitors, and
three unrelated subjects are presented. The bars represent the variation in the calculated copy number. The values were ¡0.41 for
Subject 1,¡0.63 for Subject 2,¡0.23 for the patient’s mother,¡0.79 for the patient,¡0.45 for Subject 3 and¡0.30 for the patient’s
father.
CLINICS 2012;67(8):981-985 MSX2 COPY number increase and craniosynostosis
Pelegrino KO et al.
983
4q22.1 region and craniosynostosis has been described. In
addition, no patient with case data reported in DECIPHER
who had alterations in 8q24.3 or 9q34.2-34.3 similar to those
in our patient exhibited craniosynostosis.
In a detailed study that investigated common CNVs in
Asian population, it was found that the KLHL8 (4q22.1),
VAV2 (9q34.2) and OLFM1 (9q34.3) genes exhibited copy
number variations in phenotypically normal subjects (15),
indicating that copy number losses in these genes most likely
do not contribute to the craniosynostosis phenotype. Corro-
borating these findings, a search of the Online Mendelian
Inheritance in Man (OMIM) database (16) returned no
correlations between the genes KLHL8, VAV2, DRD1,
SFXN1, DENND3, SLC45A4 and OLFM1 and clinical pheno-
types. The SARDH gene, located in the 9q34.2 region, was
shown to be associated with sarcosinemia, which is generally
considered a benign condition unrelated to neurologic
symptoms or significant clinical problems (17).
Among the CNVs found in the present work, the gain in the
5q35.2 chromosome region where the MSX2 gene is located
has already been reported to be associated with craniosynos-
tosis (8); however, the MSX2 gain was confirmed using
molecular techniques in only four cases (8-11). MSX2 is a
member of the homeobox MSX family and is related to
Drosophila muscle segment homeobox (msh). MSX2 has
important roles in tissue and organ development (3) and is
also expressed in several regions of the developing skull. In
mice, Msx2 is strongly expressed in osteogenic cells from
calvarial sutures, andMsx2 activation is thought to initiate the
release of factors from the dura mater that affect osteoblastic
suture cells (18,19).
Consistent with this role of Msx2, transgenic mice that
over expressed this gene exhibited premature suture closure
and craniofacial abnormalities (5), whereas other evidence
suggests thatMSX2 haploinsufficiency leads to a delayed or
incomplete closure of the opening between the frontal and
parietal bones. MSX2 haploinsufficiency has been demon-
strated to be responsible for the majority of foramina
parietalia permagna (FPP) cases (20-22).
There are 39 reported cases of 5q distal trisomy, but
craniosynostosis was observed in only ten of these cases.
Because most craniosynostosis patients exhibit a distal 5q
duplication, it is hypothesized that in patients with larger
duplications, MSX2 expression may be inhibited due to
extra copies of other genes (8). Additional cases may help to
elucidate the validity of this hypothesis.
In conclusion, our analysis indicates that an increase in
MSX2 copy number is correlated with this disorder,
corroborating previous findings that subjects with gains in
5q35.2 in the MSX2 gene region exhibit craniosynostosis. In
addition, the aCGH technique was shown to be useful for
the detection of CNVs throughout the whole genome.
Further studies should now be undertaken to determine
which of these CNVs are normal individual variations and
which are of clinical relevance, e.g., associated with specific
syndromes.
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